Tobin Schilke
Finanzdirektor/CFO bei REVANCE THERAPEUTICS, INC.
Vermögen: 633 871 $ am 30.04.2024
Aktive Positionen von Tobin Schilke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REVANCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05.11.2018 | - |
Finanzdirektor/CFO | 05.11.2018 | - |
Karriereverlauf von Tobin Schilke
Ehemalige bekannte Positionen von Tobin Schilke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACHAOGEN | Finanzdirektor/CFO | 05.07.2016 | 01.10.2018 |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Direktor/Vorstandsmitglied | 01.09.2012 | 01.06.2016 |
Finanzdirektor/CFO | 01.09.2012 | 01.06.2016 | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.09.2012 | 01.08.2014 |
Ausbildung von Tobin Schilke
Lafayette College | Undergraduate Degree |
University of California, Berkeley | Graduate Degree |
Johnson Graduate School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Tobin Schilke
- Erfahrung